Published in Nat Rev Rheumatol on June 01, 2010
Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis. Clin Exp Rheumatol (2011) 1.45
Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond. Nat Rev Rheumatol (2010) 1.23
Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study. Arthritis Res Ther (2012) 1.11
Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis. Mol Cell Proteomics (2011) 1.06
Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Ann Rheum Dis (2013) 1.03
Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int (2011) 1.00
ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res Ther (2012) 0.97
Pregnancy immunogenetics: NK cell education in the womb? J Clin Invest (2010) 0.96
IL-17 in the rheumatologist's line of sight. Biomed Res Int (2013) 0.95
Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol (2013) 0.93
Peptide-dependent conformational fluctuation determines the stability of the human leukocyte antigen class I complex. J Biol Chem (2014) 0.93
IL23R gene confers susceptibility to ankylosing spondylitis concomitant with uveitis in a Han Chinese population. PLoS One (2013) 0.90
An update on the contribution of the MHC to AS susceptibility. Clin Rheumatol (2014) 0.87
Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice. Biomed Res Int (2013) 0.84
FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases. Front Immunol (2015) 0.83
Defects in tendon, ligament, and enthesis in response to genetic alterations in key proteoglycans and glycoproteins: a review. Arthritis (2013) 0.82
Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis. PLoS One (2013) 0.81
Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area. Clin Rheumatol (2013) 0.81
Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis. Clin Rheumatol (2014) 0.81
Host glycans and antigen presentation. Microbes Infect (2012) 0.80
Applications of systems approaches in the study of rheumatic diseases. Korean J Intern Med (2015) 0.79
Targeted delivery of an antigenic peptide to the endoplasmic reticulum: application for development of a peptide therapy for ankylosing spondylitis. PLoS One (2013) 0.79
How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis. Clin Dev Immunol (2013) 0.78
Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers. Arthritis Res Ther (2016) 0.77
Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis. Ann N Y Acad Sci (2015) 0.77
Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction. BMC Musculoskelet Disord (2012) 0.77
Characterization of the recognition specificity of BH2, a monoclonal antibody prepared against the HLA-B27 heavy chain. Int J Mol Sci (2015) 0.76
An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease. Rheumatol Int (2014) 0.75
Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity. Nagoya J Med Sci (2015) 0.75
Association Study of Single Nucleotide Polymorphisms Rs4552569/Rs17095830 with Ankylosing Spondylitis in A Chinese Population. Open Rheumatol J (2016) 0.75
Association of adipokines, interleukin-6, and tumor necrosis factor-α concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study. J Int Med Res (2017) 0.75
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Ankylosing spondylitis and HL-A 27. Lancet (1973) 11.99
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
Dickkopf-1 is a master regulator of joint remodeling. Nat Med (2007) 7.29
Ankylosing spondylitis. Lancet (2007) 6.58
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther (2007) 5.02
Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell (1990) 4.84
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum (1997) 4.14
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med (2004) 3.88
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet (2010) 3.58
The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell (1992) 3.27
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum (1995) 3.10
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum (2010) 2.99
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum (2008) 2.75
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum (2008) 2.71
Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis (1972) 2.59
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis (2008) 2.45
IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol (2009) 2.18
The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat (2001) 2.14
Upregulation of 78-kDa glucose-regulated protein in macrophages in peripheral joints of active ankylosing spondylitis. Scand J Rheumatol (2008) 2.06
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther (2009) 2.05
Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med (2008) 1.98
Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis (2000) 1.92
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev (2008) 1.86
Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders. Arthritis Rheum (2007) 1.80
In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med (2006) 1.79
The HLA-B*2705 peptidome. Arthritis Rheum (2010) 1.76
Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest (2005) 1.73
Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1. Eur J Immunol (2008) 1.71
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum (2009) 1.65
Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum (2007) 1.61
Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction? Ann Rheum Dis (2007) 1.58
Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol (2006) 1.57
Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum (2002) 1.56
HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum (2005) 1.55
The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol (2008) 1.52
HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol (2004) 1.45
An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem (2003) 1.44
Identification of cytokines that might enhance the promoter activity of HLA-B27. J Rheumatol (2008) 1.44
Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med (1993) 1.44
ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity (2006) 1.43
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther (2009) 1.42
Bone remodeling in rheumatic disease: a question of balance. Immunol Rev (2010) 1.42
Genetics and genomics of ankylosing spondylitis. Immunol Rev (2010) 1.42
CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol (2003) 1.39
Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum (2006) 1.38
HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum (2007) 1.37
Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum (2010) 1.35
Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum (2009) 1.32
Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med (2004) 1.31
Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum (2005) 1.31
The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev (2009) 1.29
T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol (1996) 1.28
Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol (2007) 1.27
Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum (2006) 1.27
Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex. J Biol Chem (2004) 1.26
Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev (1999) 1.25
CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J Clin Invest (2000) 1.23
Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol (2006) 1.22
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess (2007) 1.19
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients. Arthritis Rheum (2004) 1.19
Genetics and the pathogenesis of ankylosing spondylitis. Curr Opin Rheumatol (2009) 1.14
The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol (2009) 1.13
Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol (2002) 1.12
Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev (2005) 1.11
Crystallization and preliminary X-ray diffraction studies of the human major histocompatibility antigen HLA-B27. Proteins (1992) 1.11
Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis. Adv Exp Med Biol (2009) 1.08
Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum (2009) 1.07
Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum (2004) 1.06
Ankylosing spondylitis is linked to Klebsiella--the evidence. Clin Rheumatol (2006) 1.06
A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis. Rheumatol Int (2009) 0.98
HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett (2006) 0.97
Major histocompatibility complex class I-restricted antigen processing and presentation. Tissue Antigens (2002) 0.97
Disease modification in ankylosing spondylitis. Nat Rev Rheumatol (2010) 0.96
The interleukin-23/interleukin-17 axis in spondyloarthritis. Curr Opin Rheumatol (2008) 0.93
Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. J Biol Chem (2005) 0.92
Basic concepts of enthesis biology and immunology. J Rheumatol Suppl (2009) 0.92
ER quality control in the biogenesis of MHC class I molecules. Semin Cell Dev Biol (2010) 0.91
The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. Adv Exp Med Biol (2009) 0.91
Recent studies on the genetic basis of ankylosing spondylitis. Curr Rheumatol Rep (2009) 0.91
Correlation between dendritic cell functional defect and spondylarthritis phenotypes in HLA-B27/HUMAN beta2-microglobulin-transgenic rat lines. Arthritis Rheum (2008) 0.90
Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability. Arthritis Rheum (2009) 0.89
Mechanisms of disease: infection and spondyloarthritis. Nat Clin Pract Rheumatol (2006) 0.89
Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res Ther (2004) 0.87
Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann Rheum Dis (2008) 0.86
Epidemiology of HLA-B27 and Arthritis. Clin Rheumatol (1996) 0.86
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. J Cell Mol Med (2011) 0.84
HLA-B27 misfolding and spondyloarthropathies. Prion (2009) 0.84
Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Ann Rheum Dis (2010) 0.84
Spondylarthritis in the absence of B lymphocytes. Arthritis Rheum (2008) 0.83
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis. Ann Rheum Dis (2004) 0.83
HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides. Ann N Y Acad Sci (2009) 0.82
MHC class I-peptide interactions and TCR recognition. Cancer Surv (1995) 0.76
The HLA-B27 peptidome: building on the cornerstone. Arthritis Rheum (2010) 0.76
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet (2011) 2.05
Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int (2009) 1.94
Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg (2009) 1.90
Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China. Rheumatol Int (2009) 1.45
Identification of cytokines that might enhance the promoter activity of HLA-B27. J Rheumatol (2008) 1.44
Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus. Int J Rheum Dis (2013) 1.39
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res (2008) 1.35
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. Arthritis Rheum (2004) 1.29
Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Arthritis Res Ther (2010) 1.17
Epidemiology of spondyloarthritis in the People's Republic of China: review of the literature and commentary. Semin Arthritis Rheum (2007) 1.16
Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Rheum (2004) 1.12
Ipsilateral cortical fMRI responses after peripheral nerve damage in rats reflect increased interneuron activity. Proc Natl Acad Sci U S A (2009) 0.99
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial. Ann Rheum Dis (2013) 0.95
The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China. Rheumatology (Oxford) (2011) 0.95
Identification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome-wide expression profiling and real-time polymerase chain reaction. Arthritis Rheum (2009) 0.93
Value of exercise capacity and heart rate recovery in older people. J Am Geriatr Soc (2003) 0.90
Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients. Rheumatol Int (2009) 0.89
Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii. Clin Rheumatol (2010) 0.89
Acute β-adrenergic activation triggers nuclear import of histone deacetylase 5 and delays G(q)-induced transcriptional activation. J Biol Chem (2012) 0.89
One-year open-label trial of thalidomide in ankylosing spondylitis. Arthritis Rheum (2002) 0.87
Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism. Rheumatol Int (2008) 0.87
Presence of reticuline in rat brain: a pathway for morphine biosynthesis. Brain Res Mol Brain Res (2003) 0.86
Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis. Eur J Pharmacol (2012) 0.86
Characterization of the mechanodynamic response of cardiomyocytes with atomic force microscopy. Anal Chem (2013) 0.85
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int (2009) 0.85
ERAP1 is associated with ankylosing spondylitis in Han Chinese. J Rheumatol (2010) 0.85
Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS. Int J Rheum Dis (2012) 0.85
A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. Rheumatol Int (2008) 0.84
Single-incision pediatric endosurgery (SIPES) splenectomy: a case-control series. J Laparoendosc Adv Surg Tech A (2013) 0.83
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. Int J Rheum Dis (2014) 0.82
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis. Int J Rheum Dis (2012) 0.82
Immunogenetic study in Chinese population with ankylosing spondylitis: are there specific genes recently disclosed? Clin Dev Immunol (2013) 0.82
Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment. Rheumatol Int (2009) 0.81
Acute injury to the immature brain with hypoxia with or without hypoperfusion. Radiol Clin North Am (2006) 0.81
Novel non-HLA-susceptible regions determined by meta-analysis of four genomewide scans for ankylosing spondylitis. J Genet (2008) 0.81
Induction of cell-cell connections by using in situ laser lithography on a perfluoroalkyl-coated cultivation platform. Chembiochem (2011) 0.81
Serum monocyte chemotactic protein-1 concentrations distinguish patients with ankylosing spondylitis from patients with mechanical low back pain. J Spinal Disord Tech (2011) 0.81
Costs and work limitation of patients with ankylosing spondylitis in China. Clin Exp Rheumatol (2014) 0.81
An animal model of chronic rheumatic valvulitis induced by formalin-killed streptococci. Rheumatol Int (2009) 0.81
HLA-B27 polymorphism in Han Chinese patients with ankylosing spondylitis: a distinctive disease association for B*2715 in a multiplex family. J Rheumatol (2009) 0.80
Sinomenine suppresses TNF-alpha-induced VCAM-1 expression in human umbilical vein endothelial cells. J Ethnopharmacol (2007) 0.79
Response to one infusion predicts subsequent improvement as well as the rate of relapse of ankylosing spondylitis infused with three pulses of infliximab. Clin Rheumatol (2006) 0.78
Prevalence of hepatitis B surface antigen in patients with ankylosing spondylitis and its association with HLA-B27: a retrospective study from south China. Rheumatol Int (2011) 0.78
Fracture mimics on temporal bone CT: a guide for the radiologist. AJR Am J Roentgenol (2012) 0.78
Acute injury to the immature brain with hypoxia with or without hypoperfusion. Magn Reson Imaging Clin N Am (2006) 0.78
Verification of Berlin algorithm for diagnosing undifferentiated spondyloarthropathy patients in Chinese population. Joint Bone Spine (2009) 0.77
miR-29a modulates tumor necrosis factor-α-induced osteogenic inhibition by targeting Wnt antagonists. Dev Growth Differ (2015) 0.77
Seronegative spondyloarthropathy--studies from the Asia Pacific region. Ann Acad Med Singapore (2007) 0.76
High-throughput screening of chemical libraries for modulators of gene promoter activity of HLA-B2705: environmental pathogenesis and therapeutics of ankylosing spondylitis. J Rheumatol (2011) 0.76
Comparison of expectations of physicians and patients with rheumatoid arthritis for rheumatology clinic visits: a pilot, multicenter, international study. Int J Rheum Dis (2012) 0.76
Evaluation of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis in Chinese patients with chronic back pain: results of a 2-year follow-up study. Int J Rheum Dis (2014) 0.75
Assessment of Conflicts of Interest in Robotic Surgical Studies: Validating Author's Declarations With the Open Payments Database. Ann Surg (2017) 0.75
Panamerican Congress of Spondyloarthropathies, Cartagena, Columbia, October 20-22, 2005: Latin American rheumatology comes of age! J Rheumatol (2006) 0.75
Limitations of lumbar spine MRI in the diagnosis of ankylosing spondylitis. Clin Exp Rheumatol (2013) 0.75
Spondyloarthropathies. Preface. Rheum Dis Clin North Am (2003) 0.75
Higher percentage of CD3⁺CD154⁺ T lymphocytes predicts efficacy of TNF-α inhibitors in active axial SpA patients. Inflammation (2014) 0.75
Changes of manifestations of 122 patients with rheumatic fever in South China during last decade. Rheumatol Int (2009) 0.75